Beilin B, Shavit Y, Razumovsky J. Effect of mild perioperative hypother on cellularimmune responses[J]. Anesthesiology, 1998, 89 (5) : 1133.
[2]
Bell W R. Present-day thrombolytic therapy: Therapeutic agents-pharmacokinetics and pharmacodynamics[J]. Rev Cardiovasc Med, 2002, 3 (Suppl 2) : S34.
[3]
Wu W, Narasaki R, Maeda F, et al. Glucosyldiacylglycerol enhances reciprocal activation of prourokinase and plasminogen[J]. Biosci Biotech Bioch, 2004, 68 (7) : 1549.
[4]
Collen D, Lijnen H R. Thrombolytic agents[J]. Thromb Haemostasis, 2005, 93 (4) : 627.
[5]
Moons L, Vanlinthout I, Roelants I, et al. Toxicology studies with recombinant staphylokinase and with SY 161-P5, a polyethylene glycol-derivatized cysteine-substitution mutant[J]. Toxicol Pathol, 2001, 29 (3) : 285.
[6]
Van de Werf F J. The ideal fibrinolytic: Can drug design improve clinical results[J]. Eur Heart J, 1999, 20 (20) : 1452.
[7]
Nicole O, Docagne F, Ali C, et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling[J]. Nat Med, 2001, 7 (1) : 59.
[8]
Nelson H, Sargent D J, Wieand H S, et al. A comparison of laparoscopically assisted and open colectomy for colon cancer[J]. N Engl J Med, 2004, 350 (20) : 2050.
[9]
Li Y, Li Z, Lin F, et al. The purification and identification of phospholipid-binding anticoagulation protein from agkistrodon halys brevicaudus venom[J]. Chin Pharmacol Bull, 2006, 22 (7) : 831.
[10]
Abib H. Effects of 60Co gamma radiation on toxicity and hemorrhagic, myonecrotic, and edema-forming activities of Cerastes cerastes venom[J]. Can J Physiol Pharmacol, 2003, 81 (12) : 1125.
[11]
Braud S, Le Bonniec B F, Bon C, et al. The stratagem utilized by the plasminogen activator from the snake Trimeresurus stejnegeri to escape serpins[J]. Biochemistry US, 2002, 41 (26) : 8478.
Liberatore G T, Samson A, Bladin C, et al. Vampire bat salivary plasminogen activator (desmoteplase) a unique fibrinolytic enzyme that does not promote neurodegeneration[J]. Stroke, 2003, 34 (2) : 537.
[14]
Hacke W, Albers G, Al-Rawi Y, et al. The desmoteplase in acute ischemic stroke trial (DIAS) a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase[J]. Stroke, 2005, 36 (1) : 66.
[15]
Renatus M, Stubbs M T, Huber R, et al. Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage[J]. Biochemistry US, 1997, 36 (44) : 13483.
[16]
Braud S, Le Bonniec B F, Bon C, et al. The stratagem utilized by the plasminogen activator from the snake Trimeresurus stejnegeri to escape serpins[J]. Biochemistry US, 2002, 41 (26): 8478.
Zhang X, Zhang J, Kuang P, et al. The effect of lumbrokinase on P-selectin and E-selectin in cerebral ischemia model of rat[J]. J Tradit Chin Med Res, 2003, 23 (2) : 141.
Tang Y, Liang D, Jiang T, et al. Crystal structure of earthworm fibrinolytic enzyme componenta: Revealing the structural determinants of its dual fibrinolytic activity[J]. J Mol Biol, 2002, 321 (1) : 57.
[25]
Chaitowitz I, Heng R, Bell K. Managing peripherally inserted central catheter-related venous thrombosis: How I do it[J]. Australas Radiol, 2006, 50 (2): 132.
[26]
Kim H S, Patra A, Paxton B E, et al. Catheter-directed thrombolysis with percutaneous rheolytic thrombectomy versus thrombolysis alone in upper and lower extremity deep vein thrombosis[J]. Cardiovasc Inter Rad, 2006, 29 (6) : 1003.
[27]
Jefferys A, Chow J S, Suranyi M G. Acute vascular access catheters for haemodialysis: Complications limiting technique survival[J]. Nephrology, 2003, 8 (1) : 16.
[28]
Davies J, Casey J, Li C, et al. Analysis of rt-PA infusion in tunnelled dialysis catheters[J]. EDTNA ERCA J,2005, 31(2) : 75.
Xiao L, Zhang R H, Peng Y, et al. Highly efficient gene expression of a fibrinolytic enzyme (subtilisin DFE) in Bacillus subtilis mediated by the promoter of α-amylase gene from Bacillus amyloliquefaciens[J]. Biotechnol Lett, 2004, 26 (17) : 1365.
[39]
Wang C, Ji B, Li B, et al. Purification and characterization of a fibrinolytic enzyme of Bacillus subtilis DC33, isolated from Chinese traditional douchi[J]. J Ind Microbiol Biotechnol, 2006, 33 (9) : 750.
Folkes A, Roe M B, Sohal S, et al. Synthesis and in vitro evaluation of a series of diketopiperazine inhibitors of plasminogen activator inhibitor-1[J]. Bioorg Med Chem Lett, 2001, 11 (19) : 2589.
Lee S Y, Kim J S, Kim J E, et al. Purification and characterization of fibrinolytic enzyme from cultured mycelia of Armillaria mellea[J]. Protein Expres Purif, 2005, 43 (1) : 10.
